Podcasts

OncLive On Air^® is a podcast from OncLive^® that provides oncology professionals with the resources and information they need to provide the best patient care. Segments cover every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. New episodes with exclusive interviews with leading oncology experts are released on Mondays and Thursdays.

Newfound Understandings of Neuroendocrine Treatment in Kentucky

August 7th 2019

We traveled to Lexington, Kentucky, for a State of the Science Summit™ on Neuroendocrine Tumors, which featured insights from the faculty from University of Kentucky Markey Cancer Center.

Perusing Breakthroughs in Breast Cancer in Pasadena

July 31st 2019

We traveled to Pasadena, California, for a State of the Science Summit™ on Breast Cancer, which featured insights from the faculty from City of Hope.

Patrick I. Borgen, MD: From the Wild West of Breast Cancer Research to Chasing Cure

July 24th 2019

Patrick I. Borgen, MD, of Maimonides Medical Center, shares his live-by mottos as a breast cancer surgeon, a patient who defined his career, and what fuels his passion to fight breast cancer and remove opioid use after surgery.

Navigating New Developments in NSCLC in Dallas

July 18th 2019

We traveled to Dallas, Texas, for a State of the Science Summit™ on Non–Small Cell Lung Cancer, which featured insights from Baylor Scott and White Health System faculty.

Tapping Into Great Progress Made in GI Cancers in Tampa

July 13th 2019

We traveled to Tampa, Florida, for a State of the Science Summit™ on Gastrointestinal Malignancies, which featured insights from the faculty from Moffitt Cancer Center and Mayo Clinic.

Hearing About Breakthroughs Made in Hematologic Malignancies in Boston

June 26th 2019

We traveled to Boston, Massachusetts, for a State of the Science Summit™ on Hematologic Malignancies, which featured insights from the faculty from Dana-Farber Cancer Institute.

Discussing Pivotal Progress in Breast Cancer in Dallas

June 19th 2019

We traveled to Dallas, Texas, for a State of the Science Summit™ on Breast Cancer, where faculty relayed the prognostic value of genomic assays in breast cancer and the scope of established and ensuing treatment approaches for those with early-stage and advanced disease.

Contemplating Key Updates in GI Cancers in Charlotte

June 12th 2019

We recently traveled to Charlotte, North Carolina, for a State of the Science Summit™ on Gastrointestinal Cancers, which featured expert insight on treatment approaches across metastatic colorectal cancer, locally advanced and metastatic pancreatic cancer, advanced hepatocellular carcinoma, neuroendocrine tumors, and advanced gastric cancer.

Observing the Latest Developments in Ovarian Cancer in NYC

May 29th 2019

We traveled to New York City, New York, for a State of the Science Summit™ on Ovarian Cancer, where faculty shared their insight on the various surgical and medical treatment modalities in advanced ovarian cancer, as well as investigational interventions that may further define standards of care.

Gaining Ground in GI Cancers in Durham

May 23rd 2019

We traveled to Durham, North Caroline, for a State of the Science Summit™ on Gastrointestinal Malignancies, where faculty shared key updates from the 2019 Gastrointestinal Symposium.

Examining Key Breast Cancer Updates in Chicago

May 16th 2019

We traveled to Chicago, Illinois, for a State of the Science Summit™ on Breast Cancer, where faculty provided a comprehensive look into present and potentially future standards of care in early-stage and advanced breast cancer subtypes.

Getting Up to Speed On Key Developments in GI Cancers in Washington DC

May 9th 2019

We traveled to Washington, D.C., for a State of the Science Summit™ on Gastrointestinal Cancer, which focused on the clinically diverse and steadily expanding therapeutic armamentariums for patients with gastrointestinal malignancies.

Highlighting Pivotal Data From 2018 ASH Annual Meeting

May 2nd 2019

We traveled to Kansas City, Missouri, for a State of the Science Summit™ on Hematologic Malignancies, which provided a comprehensive snapshot of the pivotal data that were presented at the 2018 ASH Annual Meeting.

Talking Tumors: MSK Faculty Highlight Ovarian Cancer Cases

April 25th 2019

Mario M. Leitao Jr, MD, FACOG, FACS, and Dmitriy Zamarin, MD, PhD, of Memorial Sloan Kettering Cancer Center, discuss two common clinical scenarios faced in practice, and the data to support their approaches.

Getting Educated On Advances Made With GI Cancers in Houston

April 19th 2019

We traveled to Houston, Texas, for a State of the Science Summit™ on Gastrointestinal Cancer, which focused on the rapidly evolving landscapes of colorectal cancer, gastric/GEJ cancer, pancreatic cancer, neuroendocrine tumors, and hepatocellular carcinoma.

Highlighting Breakthroughs in Breast Cancer in Nashville

April 10th 2019

We traveled to Nashville, Tennessee, for a State of the Science Summit™ on Breast Cancer, which focused on some of the practice-changing updates that have been occurring in the field.

Spotlight on Clinical Scenarios in GEJ Cancer

April 3rd 2019

In keeping up with the rapidly changing landscape of gastroesophageal junction cancer, we sat down with Joseph Chao, MD, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his treatment for his patient.

Gaining Insight Into Progress Made With Genitourinary Cancers in Pasadena

March 28th 2019

We traveled to Pasadena, California, for a State of the Science Summit™ on Genitourinary Malignancies, which focused on the rapidly evolving landscapes of kidney, bladder, and prostate cancer.

Navigating New Advances in Breast Cancer in NYC

March 20th 2019

We traveled to NewYork City, New York, for a State of the Science Summit™ on Breast Cancer, which focused on the latest updates in the rapidly evolving paradigms of triple-negative breast cancer, HER2-positive breast cancer, hormone receptor-positive, HER2-negative disease, and more.

Spotlight on Clinical Scenarios in Rectal Adenocarcinoma

March 16th 2019

We sat down with Marwan Fakih, MD, a professor in the Department of Medical Oncology and Therapeutics Research, associate director for Clinical Investigations at the Comprehensive Cancer Center, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his treatment for his patient.